Search

everythinglearnresearchcommunity

for

Search:↓

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Saw palmetto supplements may modestly improve hair regrowth with few side effects, but more research is needed.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Saw palmetto extract is generally safe and can effectively treat Lower Urinary Tract Symptoms, but its evaluation is affected by varying quality and a need for long-term studies.

There is no link between hair loss and prostate enlargement.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Lespedeza cuneata extract may help treat enlarged prostate.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Androgenetic alopecia (AGA) is a common, hereditary hair loss condition that can be slowed but not permanently reversed with available therapies.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Using tamsulosin and finasteride together for benign prostatic syndrome has increased and shows improvement in symptoms, but more reliable comparisons are needed.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.